CURANUM AG

EANS-News: CURANUM AG
Statement by the Management and Supervisory boards concerning the modification of the takeover offer

--------------------------------------------------------------------------------
  Corporate news transmitted by euro adhoc. The issuer/originator is solely
  responsible for the content of this announcement.
--------------------------------------------------------------------------------

Mergers - Acquisitions - Takeovers

München (euro adhoc) - The Management and Supervisory boards of Curanum AG
continue to unanimously support the modification of the takeover offer published
by Korian Deutschland AG, Mannheim, on February 13, 2013 and continue to
recommend that Curanum shareholders accept the offer. 

As set out in greater detail in the opinion dated February 4, 2013, all Curanum
shareholders should take into consideration all relevant circumstances in doing
so, including their individual circumstances and personal assessments concerning
the future performance in the value and stock market price of the Curanum share.
The full statement issued by the Management and Supervisory boards of Curanum AG
is available on the Internet at http://www.curanum.de/ir_korian.asp?lang=en.
Please note that the full statement from the Management Board and Supervisory
Board is only being published in German.

Munich, February 17, 2013

The Management Board


Further inquiry note:
Caroline Lutz
Leitung Unternehmensentwicklung
Tel.: +49(0)89/ 24 20 65-0
E-Mail: ir@curanum.de

end of announcement                               euro adhoc 
--------------------------------------------------------------------------------


company:     CURANUM AG
             Engelbertstraße 23-25
             D-81241 München
phone:       +49 (0)89 242065 17
FAX:         +49 (0)89 242065 10
mail:     ir@curanum.de
WWW:      http://www.curanum.de
sector:      Healthcare Providers
ISIN:        DE0005240709
indexes:     CDAX, Classic All Share, Prime All Share
stockmarkets: free trade: Berlin, Hamburg, Düsseldorf, Stuttgart, regulated
             dealing: München, regulated dealing/prime standard: Frankfurt 
language:   English
 



Weitere Meldungen: CURANUM AG

Das könnte Sie auch interessieren: